USA Biologics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.

    North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biologics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biologics market. Detailed analysis of key players, along with key growth strategies adopted by Biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Johnson & Johnson Services Inc

    • Novo Nordisk A/S

    • Amgen

    • Abbvie Inc

    • F Hoffman La Roche

    • Merck & Co Inc

    • Eli Lilly & Company

    • Addgene

    • Samsung Biologics

    • Pfizer Inc

    • Sanofi

    • Celltrion

    By Type:

    • Monoclonal Antibodies

    • Vaccines

    • Recombinant Proteins

    • Antisense

    • RNAi

    By End-User:

    • Infectious Diseases

    • Oncology

    • Immunology

    • Autoimmune Diseases

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Biologics Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

      • 1.3.2 USA Biologics Market Size and Growth Rate of Vaccines from 2016 to 2027

      • 1.3.3 USA Biologics Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027

      • 1.3.4 USA Biologics Market Size and Growth Rate of Antisense from 2016 to 2027

      • 1.3.5 USA Biologics Market Size and Growth Rate of RNAi from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

      • 1.4.2 USA Biologics Market Size and Growth Rate of Oncology from 2016 to 2027

      • 1.4.3 USA Biologics Market Size and Growth Rate of Immunology from 2016 to 2027

      • 1.4.4 USA Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Biologics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biologics by Major Types

      • 3.4.1 Market Size and Growth Rate of Monoclonal Antibodies

      • 3.4.2 Market Size and Growth Rate of Vaccines

      • 3.4.3 Market Size and Growth Rate of Recombinant Proteins

      • 3.4.4 Market Size and Growth Rate of Antisense

      • 3.4.5 Market Size and Growth Rate of RNAi

    4 Segmentation of Biologics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biologics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biologics in Infectious Diseases

      • 4.4.2 Market Size and Growth Rate of Biologics in Oncology

      • 4.4.3 Market Size and Growth Rate of Biologics in Immunology

      • 4.4.4 Market Size and Growth Rate of Biologics in Autoimmune Diseases

    5 Market Analysis by Regions

    • 5.1 USA Biologics Production Analysis by Regions

    • 5.2 USA Biologics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Biologics Landscape Analysis

    • 6.1 West USA Biologics Landscape Analysis by Major Types

    • 6.2 West USA Biologics Landscape Analysis by Major End-Users

    7 South USA Biologics Landscape Analysis

    • 7.1 South USA Biologics Landscape Analysis by Major Types

    • 7.2 South USA Biologics Landscape Analysis by Major End-Users

    8 Middle West USA Biologics Landscape Analysis

    • 8.1 Middle West USA Biologics Landscape Analysis by Major Types

    • 8.2 Middle West USA Biologics Landscape Analysis by Major End-Users

    9 Northeast USA Biologics Landscape Analysis

    • 9.1 Northeast USA Biologics Landscape Analysis by Major Types

    • 9.2 Northeast USA Biologics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Johnson & Johnson Services Inc

        • 10.1.1 Johnson & Johnson Services Inc Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Novo Nordisk A/S

        • 10.2.1 Novo Nordisk A/S Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Amgen

        • 10.3.1 Amgen Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Abbvie Inc

        • 10.4.1 Abbvie Inc Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 F Hoffman La Roche

        • 10.5.1 F Hoffman La Roche Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Merck & Co Inc

        • 10.6.1 Merck & Co Inc Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Eli Lilly & Company

        • 10.7.1 Eli Lilly & Company Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Addgene

        • 10.8.1 Addgene Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Samsung Biologics

        • 10.9.1 Samsung Biologics Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Pfizer Inc

        • 10.10.1 Pfizer Inc Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Sanofi

        • 10.11.1 Sanofi Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Celltrion

        • 10.12.1 Celltrion Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Biologics Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027

    • Figure USA Biologics Market Size and Growth Rate of Vaccines from 2016 to 2027

    • Figure USA Biologics Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027

    • Figure USA Biologics Market Size and Growth Rate of Antisense from 2016 to 2027

    • Figure USA Biologics Market Size and Growth Rate of RNAi from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027

    • Figure USA Biologics Market Size and Growth Rate of Oncology from 2016 to 2027

    • Figure USA Biologics Market Size and Growth Rate of Immunology from 2016 to 2027

    • Figure USA Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Biologics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Biologics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Biologics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biologics by Different Types from 2016 to 2027

    • Table Consumption Share of Biologics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Monoclonal Antibodies

    • Figure Market Size and Growth Rate of Vaccines

    • Figure Market Size and Growth Rate of Recombinant Proteins

    • Figure Market Size and Growth Rate of Antisense

    • Figure Market Size and Growth Rate of RNAi

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Biologics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Biologics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Infectious Diseases

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Immunology

    • Figure Market Size and Growth Rate of Autoimmune Diseases

    • Table USA Biologics Production by Regions

    • Table USA Biologics Production Share by Regions

    • Figure USA Biologics Production Share by Regions in 2016

    • Figure USA Biologics Production Share by Regions in 2021

    • Figure USA Biologics Production Share by Regions in 2027

    • Table USA Biologics Consumption by Regions

    • Table USA Biologics Consumption Share by Regions

    • Figure USA Biologics Consumption Share by Regions in 2016

    • Figure USA Biologics Consumption Share by Regions in 2021

    • Figure USA Biologics Consumption Share by Regions in 2027

    • Table West USA Biologics Consumption by Types from 2016 to 2027

    • Table West USA Biologics Consumption Share by Types from 2016 to 2027

    • Figure West USA Biologics Consumption Share by Types in 2016

    • Figure West USA Biologics Consumption Share by Types in 2021

    • Figure West USA Biologics Consumption Share by Types in 2027

    • Table West USA Biologics Consumption by End-Users from 2016 to 2027

    • Table West USA Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Biologics Consumption Share by End-Users in 2016

    • Figure West USA Biologics Consumption Share by End-Users in 2021

    • Figure West USA Biologics Consumption Share by End-Users in 2027

    • Table South USA Biologics Consumption by Types from 2016 to 2027

    • Table South USA Biologics Consumption Share by Types from 2016 to 2027

    • Figure South USA Biologics Consumption Share by Types in 2016

    • Figure South USA Biologics Consumption Share by Types in 2021

    • Figure South USA Biologics Consumption Share by Types in 2027

    • Table South USA Biologics Consumption by End-Users from 2016 to 2027

    • Table South USA Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Biologics Consumption Share by End-Users in 2016

    • Figure South USA Biologics Consumption Share by End-Users in 2021

    • Figure South USA Biologics Consumption Share by End-Users in 2027

    • Table Middle West USA Biologics Consumption by Types from 2016 to 2027

    • Table Middle West USA Biologics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Biologics Consumption Share by Types in 2016

    • Figure Middle West USA Biologics Consumption Share by Types in 2021

    • Figure Middle West USA Biologics Consumption Share by Types in 2027

    • Table Middle West USA Biologics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Biologics Consumption Share by End-Users in 2016

    • Figure Middle West USA Biologics Consumption Share by End-Users in 2021

    • Figure Middle West USA Biologics Consumption Share by End-Users in 2027

    • Table Northeast USA Biologics Consumption by Types from 2016 to 2027

    • Table Northeast USA Biologics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Biologics Consumption Share by Types in 2016

    • Figure Northeast USA Biologics Consumption Share by Types in 2021

    • Figure Northeast USA Biologics Consumption Share by Types in 2027

    • Table Northeast USA Biologics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Biologics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Biologics Consumption Share by End-Users in 2016

    • Figure Northeast USA Biologics Consumption Share by End-Users in 2021

    • Figure Northeast USA Biologics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Johnson & Johnson Services Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services Inc

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson Services Inc

    • Figure Revenue and Market Share Analysis of Johnson & Johnson Services Inc

    • Table Product and Service Introduction of Johnson & Johnson Services Inc

    • Table Company Profile and Development Status of Novo Nordisk A/S

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk A/S

    • Figure Sales and Growth Rate Analysis of Novo Nordisk A/S

    • Figure Revenue and Market Share Analysis of Novo Nordisk A/S

    • Table Product and Service Introduction of Novo Nordisk A/S

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Abbvie Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie Inc

    • Figure Sales and Growth Rate Analysis of Abbvie Inc

    • Figure Revenue and Market Share Analysis of Abbvie Inc

    • Table Product and Service Introduction of Abbvie Inc

    • Table Company Profile and Development Status of F Hoffman La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffman La Roche

    • Figure Sales and Growth Rate Analysis of F Hoffman La Roche

    • Figure Revenue and Market Share Analysis of F Hoffman La Roche

    • Table Product and Service Introduction of F Hoffman La Roche

    • Table Company Profile and Development Status of Merck & Co Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc

    • Figure Sales and Growth Rate Analysis of Merck & Co Inc

    • Figure Revenue and Market Share Analysis of Merck & Co Inc

    • Table Product and Service Introduction of Merck & Co Inc

    • Table Company Profile and Development Status of Eli Lilly & Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly & Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly & Company

    • Figure Revenue and Market Share Analysis of Eli Lilly & Company

    • Table Product and Service Introduction of Eli Lilly & Company

    • Table Company Profile and Development Status of Addgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addgene

    • Figure Sales and Growth Rate Analysis of Addgene

    • Figure Revenue and Market Share Analysis of Addgene

    • Table Product and Service Introduction of Addgene

    • Table Company Profile and Development Status of Samsung Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Biologics

    • Figure Sales and Growth Rate Analysis of Samsung Biologics

    • Figure Revenue and Market Share Analysis of Samsung Biologics

    • Table Product and Service Introduction of Samsung Biologics

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.